Year-on-Year Variations (%)
- 2024-2025: -0.11%
- 2025-2026: -0.11%
- 2026-2027: -0.11%
- 2027-2028: -0.11%
Compound Annual Growth Rate (CAGR) 2024-2028: -0.11%
The data shows a very slight, almost negligible decline in the market for antiarrhythmic medicines in Italy from 2024 to 2028. The projected CAGR of -0.11% indicates a stable market with minimal change expected.
Looking forward, key trends to watch include potential advancements in antiarrhythmic therapies, changes in healthcare policies, and the impact of increasing aging population on the demand for cardiovascular treatments. Additionally, emerging technological innovations and personalized medicine could alter market dynamics.
